Research & Innovation - Participant Portal

TOPIC : Coordinating personalised medicine research

Topic identifier: SC1-HCO-05-2016
Publication date: 14 October 2015

Types of action: CSA Coordination and support action
DeadlineModel:
Opening date:
single-stage
20 October 2015
Deadline: 13 April 2016 17:00:00

Time Zone : (Brussels time)
  Horizon 2020 H2020 website
Pillar: Societal Challenges
Work Programme Year: H2020-2016-2017
Topic Description
Specific Challenge:

By providing the right intervention to the right person at the right time, personalised medicine[1] can improve quality of life and contribute to more sustainable healthcare at Member State level. It may drive new and faster development processes and products, providing European life sciences industries with a competitive edge that can secure growth and jobs. Today, development is uneven across and within sectors, regions and Member States due to fragmented activities, insufficient communication and lack of commonly accepted solutions and standards.

Scope:

Support the development and operations of a European platform for collaboration between funders of personalised medicine research, possibly based on the International Consortium model[2]. The platform should coordinate research and innovation efforts across borders, regions and countries. It should foster an interdisciplinary approach to personalised medicine by actively involving relevant interested parties. It should develop policies, guidelines, etc. aiming to speed up the development and implementation of personalised medicine (addressing policy-related, economic, and socio-cultural factors). The platform should aim to create synergies with ongoing activities at European and national level (e.g. research infrastructures[3], ERA-NETs, personalised medicine pilot projects, EIT Health KIC[4]). It should moreover explore the best use of funds in the implementation of personalised medicine. It should actively disseminate information and best-practice examples and contribute to awareness raising in the medical professions (accelerating the reshaping of academic curricula) and among the general public. The proposal should explore scenarios for long-term sustainability.

The Commission considers that proposals requesting a contribution from the EU of around EUR 2 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Expected Impact:
  • Improved coordination across and within regional, national and pan-European research funding programmes and initiatives.
  • Faster development of personalised medicine approaches through the development of frameworks for research priorities, policies and guidelines aimed at accelerating research and implementation efforts.
  • Development of a framework for linking established research efforts, platforms, infrastructures such as biobanks or databases, building synergies between ongoing activities.
  • Increased information exchange between sectors and scientific disciplines.
  • Increased public awareness and understanding of personalised medicine approaches among the public and the medical professions.
  • Improved use of funds in the implementation of personalised medicine.

[1]Personalised medicine refers to a medical model using characterization of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.

[2]See for example the International Rare Diseases Research Consortium (IRDiRC -www.irdirc.org) or the International Human Epigenome Consortium (IHEC – www.ihec.org).

[3]http://ec.europa.eu/research/infrastructures/index_en.cfm?pg=esfri

[4]http://eit.europa.eu/eit-community/eit-health

Topic conditions and documents

Please read carefully all provisions below before the preparation of your application.
 

  1. List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
    Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).

     
  2. Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.

    Proposal page limits and layout: Please refer to Part B of the standard proposal template.

     
  3. Evaluation

    3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.

    3.2 Submission and evaluation process: Guide to the submission and evaluation process

          
  4. Indicative timetable for evaluation and grant agreement:

    Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
    Signature of grant agreements: maximum 8 months from the deadline for submission.

     
  5. Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:

    Coordination and Support Action:

    Specific provisions and funding rates
    Standard proposal template
    Standard evaluation form
    H2020 General MGA -Multi-Beneficiary
    Annotated Grant Agreement

     
  6. Additional provisions:

    Horizon 2020 budget flexibility

    Classified information

     
  7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.

     
  8. Additional documents:

    H2020 Work Programme 2016-17: Health, demographic change and wellbeing

    H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation

    H2020 Work Programme 2016-17: General Annexes

    Legal basis: Horizon 2020 - Regulation of Establishment

    Legal basis: Horizon 2020 Rules for Participation

    Legal basis: Horizon 2020 Specific Programme

 

Additional documents

Download all documents
(EN only, incl. the additional docs.)

  • Essential information for clinical studies en
  • FAQ en

Submission Service

No submission system is open for this topic.

Get support

H2020 Online Manual your online guide on the procedures from proposal submission to managing your grant.

Participant Portal FAQ – Submission of proposals.

National Contact Points (NCP) - 
contact your NCP for further assistance.

Research Enquiry Service
– ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

Enterprise Europe Network
– contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk
- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Clean Sky 2 National Contact Points
- Clean Sky 2 JU States Representative Group

Clean Sky 2 Helpdesk:
Info-Call-CPW-2014-01@Cleansky.EU

ECSEL National Contact Points
– consult Annex G of the ECSEL Work Plan

ECSEL Helpdesk:
setupecsel@ecsel.europa.eu

IMI States Representative Group (SRG)
– contact you SRG member for assistance.

IMI JU IT Helpdesk
– for IMI2 topics contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

Ethics
– for compliance with ethical issues, see the Participant Portal and Science and Society Portal

European IPR Helpdesk
assists you on intellectual property issues

CEN
and CENELEC, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at research@cencenelec.eu.

The European Charter for Researchers and the Code of Conduct for their recruitment


Partner Search Services
help you find a partner organisation for your proposal

IMI Partner Search Tool
helps you find a partner organisation for your proposal